| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 06/28/2022 | 158.62% | Cantor Fitzgerald | $10 → $6 | Maintains | Overweight |
| 07/21/2021 | 675.86% | Cantor Fitzgerald | → $18 | Initiates Coverage On | → Overweight |
| 11/15/2019 | 417.24% | Maxim Group | → $12 | Upgrades | Hold → Buy |
| 04/08/2019 | 93.97% | Alliance Global Partners | → $4.5 | Initiates Coverage On | → Buy |
| 11/01/2018 | 460.34% | Oppenheimer | → $13 | Initiates Coverage On | → Outperform |
| 07/20/2018 | 115.52% | Maxim Group | $13 → $5 | Maintains | Buy |
| 04/02/2018 | 374.14% | HC Wainwright & Co. | → $11 | Initiates Coverage On | → Buy |
| 03/19/2018 | — | Maxim Group | Upgrades | Hold → Buy |
SELLAS Life Sciences Gr Questions & Answers
The latest price target for SELLAS Life Sciences Gr (NASDAQ: SLS) was reported by Cantor Fitzgerald on June 28, 2022. The analyst firm set a price target for $6.00 expecting SLS to rise to within 12 months (a possible 158.62% upside). 2 analyst firms have reported ratings in the last year.
The latest analyst rating for SELLAS Life Sciences Gr (NASDAQ: SLS) was provided by Cantor Fitzgerald, and SELLAS Life Sciences Gr maintained their overweight rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of SELLAS Life Sciences Gr, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for SELLAS Life Sciences Gr was filed on June 28, 2022 so you should expect the next rating to be made available sometime around June 28, 2023.
While ratings are subjective and will change, the latest SELLAS Life Sciences Gr (SLS) rating was a maintained with a price target of $10.00 to $6.00. The current price SELLAS Life Sciences Gr (SLS) is trading at is $2.32, which is out of the analyst's predicted range.